20-19886681-AT-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_018993.4(RIN2):c.-36-2881del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000148 in 1,517,854 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 29)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
RIN2
NM_018993.4 intron
NM_018993.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.397
Genes affected
RIN2 (HGNC:18750): (Ras and Rab interactor 2) The RAB5 protein is a small GTPase involved in membrane trafficking in the early endocytic pathway. The protein encoded by this gene binds the GTP-bound form of the RAB5 protein preferentially over the GDP-bound form, and functions as a guanine nucleotide exchange factor for RAB5. The encoded protein is found primarily as a tetramer in the cytoplasm and does not bind other members of the RAB family. Mutations in this gene cause macrocephaly alopecia cutis laxa and scoliosis (MACS) syndrome, an elastic tissue disorder, as well as the related connective tissue disorder, RIN2 syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RIN2 | NM_018993.4 | c.-36-2881del | intron_variant | ENST00000255006.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RIN2 | ENST00000255006.12 | c.-36-2881del | intron_variant | 2 | NM_018993.4 | P1 | |||
RIN2 | ENST00000648440.1 | c.-132del | 5_prime_UTR_variant | 1/12 | P1 | ||||
RIN2 | ENST00000432334.2 | n.537-2881del | intron_variant, non_coding_transcript_variant | 4 | |||||
RIN2 | ENST00000648165.1 | n.618-2881del | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000119 AC: 16AN: 134478Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
16
AN:
134478
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000471 AC: 7AN: 148540Hom.: 0 AF XY: 0.0000751 AC XY: 6AN XY: 79926
GnomAD3 exomes
AF:
AC:
7
AN:
148540
Hom.:
AF XY:
AC XY:
6
AN XY:
79926
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000151 AC: 209AN: 1383376Hom.: 0 Cov.: 30 AF XY: 0.000154 AC XY: 105AN XY: 683074
GnomAD4 exome
AF:
AC:
209
AN:
1383376
Hom.:
Cov.:
30
AF XY:
AC XY:
105
AN XY:
683074
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000119 AC: 16AN: 134478Hom.: 0 Cov.: 29 AF XY: 0.0000784 AC XY: 5AN XY: 63792
GnomAD4 genome
AF:
AC:
16
AN:
134478
Hom.:
Cov.:
29
AF XY:
AC XY:
5
AN XY:
63792
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 04, 2022 | The RIN2 gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_001242581.1, and corresponds to NM_018993.3:c.-2917del in the primary transcript. This sequence change creates a premature translational stop signal (p.Ser6Leufs*45) in the RIN2 gene. However, it is currently unclear if variants that occur in this region of the gene cause disease. This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RIN2-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at